Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Cancers|August 19, 2020
MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast CancerAlessandra Cataldo, Sandra Romero-Cordoba, Ilaria Plantamura, et al.
Cancer Letters|October 4, 2016
Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayersMartina Di Modica, Viola Regondi, Marco Sandri, et al.
Cancers|November 11, 2022
The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future ProspectiveValentina Fogazzi, Marcel Kapahnke, Alessandra Cataldo, et al.
Frontiers in Immunology|March 11, 2026
MiRNAs: a call to arms that shapes the plasticity of tumor associated macrophages in breast cancerValentina Fogazzi, Giulia Cosentino, Michele Sommariva, et al.
Breast (Edinburgh, Scotland)|March 30, 2018
MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancerMatteo Dugo, Xiaoyan Huang, Marilena V Iorio, et al.
Oncotarget|December 2, 2015
miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage responseAlessandra Cataldo, Douglas G Cheung, Andrea Balsari, et al.
Plos One|March 14, 2013
Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulationLoris De Cecco, Martina Berardi, Michele Sommariva, et al.
Cancer Research|March 12, 2009
microRNA-205 regulates HER3 in human breast cancerMarilena V Iorio, Patrizia Casalini, Claudia Piovan, et al.
Non-Coding RNA|January 22, 2024
Genetic Loss of miR-205 Causes Increased Mammary Gland DevelopmentAlessandra Cataldo, Douglas G Cheung, John P Hagan, et al.
Breast (Edinburgh, Scotland)|July 3, 2007
Relationship between p53 and p27 expression following HER2 signalingPatrizia Casalini, Marilena V Iorio, Valeria Berno, et al.
Pageof 6